The pharmacogenomics market involves the use of genomic information to guide prescription drug therapies. Pharmacogenomics is playing a key role in improving patient outcomes for treatment of various diseases like cancer, infectious diseases, neurological disorders and cardiovascular diseases. Molecular diagnostics are increasingly being adopted for genetic testing prior to prescribing drugs in order to avoid adverse drug reactions and determine optimal dosages based on a person's genetic ... Read more